Discontinuation of secondary prophylaxis for penicilliosis marneffei in AIDS patients responding to highly active antiretroviral therapy [2]
Journal
AIDS
Journal Volume
16
Journal Issue
4
Pages
672-673
Date Issued
2002
Author(s)
SDGs
Other Subjects
amphotericin B; antifungal agent; antiretrovirus agent; CD4 antigen; itraconazole; acquired immune deficiency syndrome; highly active antiretroviral therapy; human; Human immunodeficiency virus 1; Human immunodeficiency virus infection; letter; leukocyte count; major clinical study; mycosis; opportunistic infection; Penicillium marneffei; priority journal; treatment outcome; virus infection; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; HIV Infections; Humans; Itraconazole; Mycoses; Penicillium; Withholding Treatment
Type
letter
